- ANGLE has been granted a European patent for its Parsortix liquid biopsy system, which harvests cancer cells from blood for medical analysis. The European patent provides protection over a wide range of uses of the Parsortix technology and extends the duration of patent coverage out to 2034.

Granted patents have already been secured in the United States, Canada, China and Australia.

Corresponding patent applications have been made worldwide in countries considered to represent substantial markets for Parsortix products.

Story provided by